A PHASE3, OPEN – LABEL LONG-TERM EXTENSION STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BMN111 IN CHILDREN WITH ACHONDROPLASIA_111-302 14 agosto, 2019 / 0 TwittearCompartirCompartir0 CompartirTwittearCompartirCompartir0 Compartir